/
Keros Therapeutics, Inc.
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.
Mentions
1 mention · latest on 1 Jan 2026
See which tracked investors hold Keros Therapeutics, Inc. →Ownership and position changes on OwnershipTrace
| Generals and WorkoutsBlog | 2025 portfolio review | - | 1 Jan 2026 |